US Startup M&A Hits $119.8B in 2026 Led by SpaceX's $60B Cursor Deal
US startup M&A spending reaches $119.8B in 2026, paced by SpaceX's $60B Cursor acquisition. Biotech and AI deals dominate the top 10 list.
What Happened
According to a Crunchbase News analysis published June 25, 2026, US acquirers have spent at least $119.8 billion buying private, venture-backed companies so far this year — putting 2026 on pace to exceed 2025's record-setting M&A total.
The headline transaction is SpaceX's $60 billion acquisition of Anysphere, the parent company of AI coding tool Cursor. The deal, first announced as an option in April 2026, closed this month following SpaceX's IPO. It represents the largest startup acquisition in history, nearly double the previous record-holder, Google's $32 billion purchase of Wiz. For context, the next-largest startup M&A deal before this was Facebook's $19 billion WhatsApp acquisition in 2014.
Roughly half of all 2026 US startup M&A spending comes from this single transaction.
The remaining top 10 largest disclosed deals range from $2 billion to $7 billion:
- Eli Lilly / Kelonia Therapeutics — up to $7B (gene therapies, cancer focus)
- Capital One / Brex — $5.15B (business credit cards and accounts)
- Qualcomm / Modular — $4B (AI chip startup, announced June 24)
- Salesforce / Fin — $3.6B (AI customer experience tools)
- Autodesk / MaintainX — $3.6B (industrial AI platform)
- Eli Lilly / Orna Therapeutics — up to $2.4B (RNA therapeutics)
- Eli Lilly / Ajax Therapeutics — up to $2.3B (blood cancer therapies)
Biotech accounted for half of the top 10 deals, though most biotech figures represent maximum potential prices contingent on clinical and commercialization milestones.
Why It Matters
The 2026 M&A surge signals a fundamental shift in how large enterprises and newly public mega-companies are acquiring AI and deep-tech capabilities. Rather than building in-house over years, they're buying category leaders at unprecedented premiums.
SpaceX's Cursor acquisition specifically validates that AI developer tooling has become strategic infrastructure — not a productivity nicety, but a capability worth $60 billion. This reframes the entire AI coding tools market (GitHub Copilot, Zed, Replit, Continue) as a battleground for strategic ownership.
For operators, the exit environment has materially improved compared to the 2023-2024 drought. But the bar for acquisition-worthy companies has shifted: acquirers want category leaders with proven revenue traction and defensible moats. The heavy biotech presence also demonstrates that AI's acquisition value isn't limited to software — applied AI in life sciences is producing exit-ready targets at scale.
Who Is Affected
AI startup founders and investors are the most directly affected. The exit window is open, multiple billion-dollar-plus transactions are closing, and buyer appetite spans software, biotech, and infrastructure.
Enterprise technology buyers and CIOs should note that acquired AI tools may shift pricing, roadmap priorities, or integration paths. Cursor under SpaceX ownership is the most prominent example, but Brex under Capital One and Modular under Qualcomm carry similar dynamics.
Developers and teams building on these tools should assess dependency risk. Cursor users in particular face uncertainty about product direction under a new owner with no prior software tooling track record.
Strategic Implications
For AI Startup Founders
The exit market is open but selective. Acquirers are paying premiums for category leaders with revenue traction — not for promising pre-revenue bets. If you're not in a clear category leadership position, the current environment favors strategic acquisition paths over IPO attempts. The presence of three Eli Lilly biotech deals also suggests that acquirers are willing to do multiple transactions in the same vertical; if you're in a hot sector, identify which acquirers are already buying.
For Developers/Operators Building with AI APIs
Cursor's acquisition by SpaceX introduces real uncertainty around product direction, pricing, and independence. If your engineering team relies heavily on Cursor, evaluate alternatives now — GitHub Copilot, Zed, or open-source options like Continue. Track whether SpaceX maintains Cursor's independent roadmap or integrates it into a broader internal tooling strategy. Similarly, Qualcomm's acquisition of Modular may affect AI chip accessibility and pricing for startups building custom inference infrastructure.
For Non-Technical Business Owners Evaluating AI Tools
The wave of acquisitions means AI tools you adopt today may be acquired, integrated, repriced, or sunset within 12-18 months. Prioritize vendors with clear data portability policies. Avoid over-coupling your workflows to any single AI platform. The Salesforce-Fin and Autodesk-MaintainX deals are reminders that even established AI tools can change ownership quickly.
What to Watch Next
Monitor whether SpaceX announces changes to Cursor's pricing, team structure, or product roadmap in the next 60 days — that will signal whether this is a platform play or a talent acquisition. Watch for additional AI infrastructure M&A in Q3 2026, particularly in the AI chip and developer tooling sectors where Qualcomm's Modular acquisition may trigger competitive responses.
Frequently Asked Questions
Q: How much has been spent on US startup M&A in 2026?
A: At least $119.8 billion as of June 25, 2026, according to Crunchbase News. This puts the year on pace to exceed 2025's record total.
Q: What is the largest startup acquisition ever?
A: SpaceX's $60 billion acquisition of Anysphere (Cursor), closed in June 2026. It nearly doubles the previous record — Google's $32 billion acquisition of Wiz.
Q: What sectors are seeing the most M&A activity in 2026?
A: AI tooling and biotech dominate the top 10. Biotech accounts for half of the largest deals, driven primarily by Eli Lilly's three acquisitions. AI software deals include Cursor, Modular, Fin, and MaintainX.